Catatonia: Back to the future of the neuropsychiatric syndrome

Jorge Cuevas-Esteban*, David Sanagustin, María Iglesias-González

*Corresponding author for this work

Research output: Contribution to journalReview articleResearchpeer-review

7 Citations (Scopus)

Abstract

Catatonia is an undertreated and underdiagnosed neuropsychiatric syndrome whose prognosis is benign if treated early, thus avoiding possible complications and compromising the health of patients. The latest epidemiological studies indicate a prevalence of catatonia of 9.2%, being frequent in medical pathologies (especially neurological ones), as well as in psychiatric pathologies. The use of validated scales is recommended for its diagnosis, to be able to measure the severity and response to treatment. Once catatonia has been identified, it is necessary to perform a protocolized diagnostic study of the underlying aetiology («Catatonia Workup»). Treatment of choice is benzodiazepines and electroconvulsive therapy. In recent years, new therapeutic alternatives such as non-invasive transcranial magnetic stimulation have emerged. In this review we propose several initiatives to promote the dissemination and knowledge of catatonia in the clinical setting.

Translated title of the contributionCatatonia: regreso al futuro del síndrome neuropsiquiátrico
Original languageEnglish
Pages (from-to)369-377
Number of pages9
JournalMedicina clinica
Volume158
Issue number8
DOIs
Publication statusPublished - 22 Apr 2022

Keywords

  • Catatonia
  • COVID-19
  • Delirium
  • ECT
  • Lorazepam challenge test
  • Neuropsychiatry

Fingerprint

Dive into the research topics of 'Catatonia: Back to the future of the neuropsychiatric syndrome'. Together they form a unique fingerprint.

Cite this